Anetumab

Tax included
Anetumab (Anti-MSLN Antibody) is an anti-mesothelin (MSLN) antibody. MSLN is a tumor-associated antigen. Anetumab can be used to synthesis Anetumab ravtansine, a MSLN-targeting antibody-drug conjugate (ADC). Anetumab can be used for the research of malignant tumor.
MedChemExpress 
HY-P99352

Data sheet

Size
Multiple sizes
Reactivity
Mesothelin
Application
Cancer-programmed cell death
CAS
1954758-84-9